Noticias de SLS_US

Noticias del mercado

Últimas noticias sobre SLS_US — 117 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SLS_US ✕ 117 resultados
23/03/2026 SLS_US — StocksToTrade
Sellas Life Sciences: New Price Targets Signal Optimism Amid Clinical Progress
20/03/2026 SLS_US — 24/7 Wall St.
Sellas Life Sciences Group : SLS
20/03/2026 SLS_US — Stock Titan
SELLAS (NASDAQ: SLS) registers shelf and $150M ATM with TD Cowen
19/03/2026 SLS_US — Yahoo Finance
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
19/03/2026 SLS_US — TradingView
SELLAS Life Sciences 2025 10-K: Revenue $0.0M, EPS $(0.25)
19/03/2026 SLS_US — GlobeNewswire
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
19/03/2026 SLS_US — Stock Titan
SELLAS nears key leukemia trial readout after raising $42.6M in Q1
19/03/2026 SLS_US — GlobeNewswire
SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update
19/03/2026 SLS_US — Stock Titan
[8-K] SELLAS Life Sciences Group, Inc. Reports Material Event | SLS 8-K Filing
17/03/2026 SLS_US — GlobeNewswire
SELLAS Life Sciences to Present Preclinical Data
17/03/2026 SLS_US — Stock Titan
Experimental leukemia drug SLS009 triggers cancer cell death in lab tests
17/03/2026 SLS_US — GlobeNewswire
SELLAS Life Sciences to Present Preclinical Data
17/03/2026 SLS_US — Investing.com
Sellas to present preclinical data on SLS009 at cancer conference
17/03/2026 SLS_US — Yahoo Finance
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
16/03/2026 SLS_US — TradingView
Sellas Life Sciences Group Inc expected to post a loss of 6 cents a share - Earnings Preview
12/03/2026 SLS_US — GlobeNewswire
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
12/03/2026 SLS_US — Yahoo Finance
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009
12/03/2026 SLS_US — Investing.com
SELLAS enrolls first patient in Phase 2 AML trial of SLS009
12/03/2026 SLS_US — Stock Titan
AI-guided leukemia trial enrolls those unlikely to benefit from aza/ven therapy
12/03/2026 SLS_US — GlobeNewswire
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009

Página 5 de 6

keyboard_arrow_up